Windham’s Yee on Why She Thinks Medtech’s Renaissance is Drawing Future New Leaders

Cynthia Yee is a Principal at Windham Venture Partners and is a Board Director at ClarVista Medical and NeuSpera Medical and a Board Observer at Cartiva, Personal Genome Diagnostics (PGDx) and VytronUS. She has diverse experience investing in public and private healthcare companies across the medical device and healthcare IT sectors. Prior to joining Windham, Cynthia served as Director of Business Development & Strategic Marketing at Advanced Cardiac Therapeutics (ACT), a venture-backed medical device start-up. Previously, she was an Associate on the Healthcare team at New Enterprise Associates (NEA) and focused on investments in medical device, biopharmaceutical and healthcare services companies. Cynthia began her career in equity research, covering medical devices at Piper Jaffray and biotechnology at Pacific Growth Equities.

Cynthia graduated from the University of California, Berkeley, where she earned a BA in Integrative Biology and a BS in Business Administration from the Haas School of Business.